🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to assess the relative bioavailabilit...
Status
Completed
Location
Teva Investigational Site 12141
Start Date
2025-03-10
Trial ID
NCT06911567
Treatments Being Tested
To determine whether new 80 mg atorvastatin tablets are bioequivalent to 80...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-07
Trial ID
NCT00917644
Treatments Being Tested
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
The purpose of this study is to compare the efficacy of once daily dosing w...
Status
Completed
Location
Multiple Locations
Start Date
2002-04
Trial ID
NCT00641979
Treatments Being Tested
To evaluate patient acceptance of a new MiraLax dose formulation in childre...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00319670
Treatments Being Tested
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested